Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial.
- DOI
- 10.1038/s41591-025-03939-6
- Published
- 2025-08-31
- Container
- Nat Med
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41591-025-03939-6,
title = {Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial.},
author = {Borlaug BA and Testani JM and Petrie MC and Wang Z and Cunningham J and Adams KF and Amir O and Bělohlávek J and Bocchi E and Freitas A and Hominal M and Kadokami T and Merkely B and Miller CA and Nuñez J and Verma S and Yilmaz MB and Oru E and Sam F.},
year = {2025},
journal = {Nat Med},
doi = {10.1038/s41591-025-03939-6},
url = {https://doi.org/10.1038/s41591-025-03939-6}
}RIS
TY - JOUR TI - Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial. AU - Borlaug BA AU - Testani JM AU - Petrie MC AU - Wang Z AU - Cunningham J AU - Adams KF AU - Amir O AU - Bělohlávek J AU - Bocchi E AU - Freitas A AU - Hominal M AU - Kadokami T AU - Merkely B AU - Miller CA AU - Nuñez J AU - Verma S AU - Yilmaz MB AU - Oru E AU - Sam F. PY - 2025 JO - Nat Med DO - 10.1038/s41591-025-03939-6 UR - https://doi.org/10.1038/s41591-025-03939-6 ER -
APA
BA, B., JM, T., MC, P., Z, W., J, C., KF, A., O, A., J, B., E, B., A, F., M, H., T, K., B, M., CA, M., J, N., S, V., MB, Y., E, O., & F., S. (2025). Effects of volenrelaxin in worsening heart failure with preserved ejection fraction: a phase 2 randomized trial.. Nat Med. https://doi.org/10.1038/s41591-025-03939-6
Source records
- europe-pmc · retrieved 2026-09-26T08:38:51.825Z